The primary objectives of the study were to facilitate the evaluation of patients with cryptogenic stroke through early initiation of long‐term cardiac rhythm monitoring with direct inpatient ...

(NASDAQ:IRTC), a company specializing in digital healthcare solutions, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Zio AT cardiac ...